⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5950972 | 0.97 | — | — | |
| SCHEMBL16845049 | 0.85 | — | — | |
| SCHEMBL5950567 | 0.81 | ALDH1A1 (0.41) | — | |
| Hydrochloric Acid SCHEMBL5950973 | 0.79 | ALDH1A1 (0.39) | — | |
| SCHEMBL1892585 | 0.79 | — | — | |
| SCHEMBL22855447 | 0.78 | EPHX1 (0.47) | — | |
| SCHEMBL14712717 | 0.78 | LMNA (0.34) | — | |
| SCHEMBL23605296 | 0.77 | — | — | |
| SCHEMBL5247896 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL1067794 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240279420-A1 | POLYOL BLENDED LIQUID COMPOSITION FOR PRODUCTION OF HYDROCHLOROFLUOROOLEFIN BLOWN POLYURETHANE FOAM, AND ITS APPLICATION | TOSOH CORPORATION (JP) | 2024-08-22 | — | — | US | disclosed |
| WO-2022239734-A1 | POLYOL-BASED MIXED LIQUID COMPOSITION FOR PRODUCING HYDROCHLOROFUROOLEFIN FOAMED POLYURETHANE FOAM, AND USE THEREOF | 東ソー株式会社 | 2022-11-17 | — | — | WO | disclosed |
| EP-3873938-A1 | DC-SIGN ANTIBODY CONJUGATES COMPRISING STING AGONISTS | Novartis AG (CH) | 2021-09-08 | — | — | EP | disclosed |
| CN-113348181-A | DC-SIGN antibody conjugates comprising a STING agonist | 诺华股份有限公司 | 2021-09-03 | — | — | CN | disclosed |
| US-20200207782-A1 | CHEMICALLY ACTIVATED WATER-SOLUBLE PRODRUG | SUMITOMO DAINIPPON PHARMA CO., LTD (JP) | 2020-07-02 | — | — | US | disclosed |
| CN-110799218-A | Antibody conjugates comprising STING agonists | 诺华股份有限公司 | 2020-02-14 | — | — | CN | disclosed |
| WO-2017120355-A1 | DIHYDROQUINOLINES AND USES THEREOF | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2017-07-13 | — | — | WO | disclosed |
| EP-1602362-B1 | DRUG COMPOSITION HAVING ACTIVE INGREDIENT ADHERED AT HIGH CONCENTRATION TO SPHERICAL CORE | TAKEDA PHARMACEUTICAL (JP) | 2016-09-28 | — | — | EP | disclosed |
| US-8449911-B2 | Drug composition having active ingredient adhered at high concentration to spherical core | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-05-28 | — | — | US | disclosed |
| US-20120041088-A1 | FOAMING ADDITIVE FOR PRODUCING POLYURETHANE FOAM, AND METHOD FOR PRODUCING RIGID POLYURETHANE FOAM BY USING IT | TOSOH CORPORATION (JP) | 2012-02-16 | — | — | US | disclosed |
| US-20060159760-A1 | Drug composition having active ingredient adhered at high concentration to spherical core | AOYAMA & PARTNERS | 2006-07-20 | — | — | US | disclosed |
| EP-1602362-A1 | DRUG COMPOSITION HAVING ACTIVE INGREDIENT ADHERED AT HIGH CONCENTRATION TO SPHERICAL CORE | Takeda Pharmaceutical Company Limited (JP) | 2005-12-07 | — | — | EP | disclosed |